Save Science: Protect MS Research Funding

Scientific research fuels medical breakthroughs, enhances quality of life, and moves us closer to a cure for multiple sclerosis (MS). But right now, federal funding for MS research is at risk—jeopardizing critical studies that drive advancements in treatment and care for those living with MS.

Why This Matters

Congress plays a critical role in determining the future of MS research funding. Cuts to programs like the Multiple Sclerosis Research Program (MSRP) under the Congressionally Directed Medical Research Program (CDMRP) could halt progress in understanding, treating, and ultimately curing MS. Without sustained investment, life-changing research could be delayed or lost altogether.

ACTRIMS: Leading the Charge in MS Research

As a global leader in MS research, ACTRIMS (Americas Committee for Treatment and Research in Multiple Sclerosis) is committed to advancing scientific collaboration, driving innovation, and supporting the MS community. Consistent federal funding is essential to continue groundbreaking research and ensure that future treatments become reality.

How You Can Help

✔Contact Your Legislators – Urge them to protect federal MS research funding and oppose cuts that would slow scientific progress.
✔ Share Why MS Research Matters – Nearly 1 million Americans live with MS, including over 70,000 veterans. Federal funding supports breakthrough studies that lead to better treatments and improved care.

Every voice matters. Tell Congress: Protect MS research funding before it’s too late.

Take Action Today: Congress.gov